New clinical trial studies pancreatic cancer tumor traits to uncover better treatments

(Stand Up To Cancer) A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors. The Pancreatic Cancer Convergence Dream Team is funded by the Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer ® (SU2C), SU2C Canada and Pancreatic Cancer Canada.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news